CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling

Nat Neurosci. 2010 May;13(5):622-9. doi: 10.1038/nn.2529. Epub 2010 Apr 11.

Abstract

Stress and anxiety disorders are risk factors for depression and these behaviors are modulated by corticotrophin-releasing factor receptor 1 (CRFR1) and serotonin receptor (5-HT(2)R). However, the potential behavioral and cellular interaction between these two receptors is unclear. We found that pre-administration of corticotrophin-releasing factor (CRF) into the prefrontal cortex of mice enhanced 5-HT(2)R-mediated anxiety behaviors in response to 2,5-dimethoxy-4-iodoamphetamine. In both heterologous cell cultures and mouse cortical neurons, activation of CRFR1 also enhanced 5-HT(2) receptor-mediated inositol phosphate formation. CRFR1-mediated increases in 5-HT(2)R signaling were dependent on receptor internalization and receptor recycling via rapid recycling endosomes, resulting in increased expression of 5-HT(2)R on the cell surface. Sensitization of 5-HT(2)R signaling by CRFR1 required intact PDZ domain-binding motifs at the end of the C-terminal tails of both receptor types. These data suggest a mechanism by which CRF, a peptide known to be released by stress, enhances anxiety-related behavior via sensitization of 5-HT(2)R signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamines / pharmacology
  • Animals
  • Anxiety / drug therapy
  • Anxiety / metabolism*
  • Anxiety / physiopathology
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Biotinylation / methods
  • Cells, Cultured
  • Corticotropin-Releasing Hormone / pharmacology
  • Cyclic AMP / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Fluorobenzenes / pharmacology
  • Hormones / pharmacology
  • Humans
  • Inositol Phosphates / metabolism
  • Ionophores / pharmacology
  • Male
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Mice
  • Monensin / pharmacology
  • Mutation / genetics
  • Neurons
  • Piperidines / pharmacology
  • Prefrontal Cortex / cytology
  • Rats
  • Reaction Time / drug effects
  • Receptors, Corticotropin-Releasing Hormone / genetics
  • Receptors, Corticotropin-Releasing Hormone / physiology*
  • Receptors, Serotonin, 5-HT2 / genetics
  • Receptors, Serotonin, 5-HT2 / metabolism*
  • Serotonin / pharmacology
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Agents / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Transfection

Substances

  • Amphetamines
  • Fluorobenzenes
  • Hormones
  • Inositol Phosphates
  • Ionophores
  • Piperidines
  • Receptors, Corticotropin-Releasing Hormone
  • Receptors, Serotonin, 5-HT2
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Agents
  • Serotonin
  • CRF receptor type 1
  • Corticotropin-Releasing Hormone
  • Monensin
  • Cyclic AMP
  • volinanserin
  • 4-iodo-2,5-dimethoxyphenylisopropylamine